Skip to content
  • Saturday, 15 August 2026
  • 1:23 am
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • Identification of CD99L2 Gene Variants as a Novel Driver of X-linked Spastic Ataxia Unlocks New Pathways in Neurodegenerative Research
Neuroscience & Brain Research

Identification of CD99L2 Gene Variants as a Novel Driver of X-linked Spastic Ataxia Unlocks New Pathways in Neurodegenerative Research

Rifan Muazin Jun 23, 2026 0

In a significant breakthrough for the field of clinical genetics and neurology, a collaborative team of researchers in Germany has…

Read More
Environmental & Analytical Chemistry

Genetic Variants Influence Weight Loss and Side Effect Efficacy of GLP-1 Drugs

Abdurrohim Arsyad Apr 16, 2026 0

A large-scale study analyzing the genetic data of 23andMe customers has identified specific variants in two genes that significantly influence…

Read More
J&J Poster Puts Spravato Remission Data at Center of Treatment-Resistant Depression Growth PushStudy Reveals Role of Sleep Like Brain Activity in ADHD Related Attention ChallengesVast Clouds of Interstellar Water Ice Found in Galactic NurseriesCognito Therapeutics and Ochsner Health Forge Landmark Partnership to Advance Brain Health Innovation in the Gulf South
MEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthJapan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactLLMOps in 2026: The 10 Tools Every Team Must HaveThe Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals Plummet
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’sKing’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid DecompositionSanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
YOU MAY HAVE MISSED
Laboratory Automation & Robotics
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’s
Lana Keisha Jul 25, 2026
Neuroscience & Brain Research
King’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286
Rifan Muazin Jul 25, 2026
Advanced Materials Science
Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid Decomposition
Nila Kartika Wati Jul 25, 2026
Pharmaceutical R&D
Sanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
Teuku Ryan Jul 25, 2026

Copyright © 2025 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ